PDEX - Kewajiban jangka dawa marang modal Pro-Dex Inc.

Simbol lan logo merek Pro-Dex Inc. (PDEX)

Pro-Dex, Inc. (PDEX) generates revenue through the sale of specialized surgical drills and power systems. The long-term debt-to-equity trend illustrates current financial stability, with the 0.29 mark capturing this metric. Equipment reliability is supported by high-cost air freight, while production stability is ensured by a diversified pool of suppliers for microchips and precision alloys.

Pro-Dex Corp (PDEX): Utang jangka dawa marang modal saka 04.07.2022 nganti 27.10.2026
Barang utama Pro-Dex, Inc.

Investors seek a balance between asset value and the quality of capital management. This ratio compares liabilities with a maturity of over one year to equity to measure financial stability. This is critical for Pro-Dex, Inc. (PDEX), as the development of its surgical equipment ecosystem requires stable, long-term financing. An analysis of the borrowing structure allows for an assessment of risks during production scaling. The dynamics of these processes are reflected in this long-term debt-to-equity ratio chart.

Analisis pesaing

Rasio utang jangka dawa marang ekuitas Intuitive Surgical, Inc.|Danaher Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Becton Dickinson & Company (BDX)|STE - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal westpharma.com WST|Utang jangka dawa marang modal BAX (Baxter)|MASI - Rasio tanggungan utang jangka dawa marang modal|STVN (Stevanato) - Utang jangka dawa marang modal|Teleflex Corp (TFX) - Rasio utang jangka dawa marang ekuitas|MMSI (Merit Medical Systems) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NVST|Utang jangka dawa marang ekuitas ICU Medical (ICUI)|Utang jangka dawa marang ekuitas Dentsply Sirona Inc XRAY|Rasio utang jangka dawa marang ekuitas LeMaitre|Koefisien utang jangka dawa marang modal AtriCure Medical ATRC|Utang jangka dawa marang modal STAA (STAAR Surgical Company)|NAGE: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ZimVie|ANGO (AngioDynamics Inc) - Rasio utang jangka dawa marang modal|CERS: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Teknova Inc (TKNO)|Rasio utang jangka dawa marang ekuitas Monogram Technologies|Rasio silihan jangka dawa marang modal STSS (sharpstechnology.com)|Utang jangka dawa marang ekuitas InfuSystem Holdings, Inc.|UTMD - Koefisien utang jangka dawa marang modal|KORU Medical Systems Inc. - Rasio utang jangka dawa marang ekuitas|NYXH: Utang jangka dawa marang modal|MBOT (Microbot Medical Inc.) - Utang jangka dawa marang ekuitas|zentek.com (ZTEK) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal ELUT (Elutia)|Kewajiban jangka dawa marang modal MLSS|Utang jangka dawa marang ekuitas NEXGEL, Inc NXGL|Rasio utang jangka dawa marang modal retractable.com RVP|Rasio utang jangka dawa marang ekuitas Harvard Bioscience, Inc. (HBIO)|femasys.com - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas MHUA (Meihua Medical)|POAI: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas callanjmb.com (CJMB)|ATRI (Atrion Corporation Inc.) - Kewajiban jangka dawa marang ekuitas|NURO - Utang jangka dawa marang ekuitas